Abstract Background Coronavirus disease 2019 (COVID‐19) can lead to systemic
coagulation activation and thrombotic complications. Objectives To investigate the incidence …

Objective We have summarized the incidence, anticoagulation panels, laboratory
characteristics, and mortality of venous thromboembolism (VTE) in hospitalized patients with …

Introduction COVID‐19 is associated with an increased risk of venous thromboembolism
(VTE), but there is great variation among reported incidence rates. Most previous studies …

Venous thromboembolism (VTE) has emerged as an important issue in patients with COVID-
19. The purpose of this study is to identify the incidence of VTE and mortality in COVID-19 …

Venous Thromboembolism in Hospitalized COVID-19 Patients : American Journal of
Therapeutics Venous Thromboembolism in Hospitalized COVID-19 Patients : American Journal …

Background: Accumulating evidence suggests that coronavirus disease 2019 (COVID-19) is
associated with hypercoagulative status, particularly for critically ill patients in the intensive …

Arterial thrombotic disease (atherosclerotic cardiovascular disease, CVD) and venous
thromboembolism (VTE)(comprising of deep vein thrombosis (DVT) and pulmonary …

To establish the impact of COVID-19 on the pre-test probability for VTE in patients with
suspected VTE. This was a retrospective, observational, cross-sectional study of patients 18 …

ABSTRACT COVID-19 pneumonia has been associated with high rates of thrombo-embolic
complications, mostly venous thromboembolism (VTE), which is thought to be a combination …

Previous studies have suggested that COVID-19 pneumonia is associated with an increased
risk of venous thromboembolism (VTE). This study aimed to investigate the incidence of VTE …